Denali Therapeutics Inc. (DNLI) Tops Q1 EPS by 2c

Denali Therapeutics Inc. (NASDAQ: DNLI) reported Q1 EPS of ($0.68), $0.02 better than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Denali Therapeutics Inc. (DNLI) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• SAS CEO van der Werff emerges as frontrunner for Air Canada top job - Bloomberg
• Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank